Abstract 16585: Prediction of Atherosclerotic Cardiovascular Disease Mortality in a Nationally Representative Cohort Using Set of Risk Factors From Pooled Cohort Risk Equations

Circulation ◽  
2014 ◽  
Vol 130 (suppl_2) ◽  
Author(s):  
Zefeng Zhang ◽  
Quanhe Yang ◽  
Barbara Bardenheier ◽  
Cathleen Gillespie ◽  
Barbara Bowman

Introduction: The American College of Cardiology/American Heart Association Pooled Cohort risk equations were developed to estimate atherosclerotic cardiovascular disease (ASCVD) risk. It is unclear if the set of risk factors might predict ASCVD mortality in a nationally representative cohort. Hypothesis: We assessed the performance of the set of risk factors developed by the Pooled Cohort equations in the prediction of ASCVD mortality by sex and race-ethnicity. Methods: We used the Third National Health and Nutrition Examination Survey Linked Mortality File (NHANES III 1988-2006, n=7,042) and included participants 40-79 years of age without CVD at baseline. We used Cox proportional hazard models to estimate the predicted probability of ASCVD death at 10-year by sex and race-ethnicity (non-Hispanic white (NHW), non-Hispanic black (NHB), and Mexican American (MA)). We calculated the discrimination and calibration for each sex-race-ethnicity model. Results: We documented 409 ASCVD deaths during 62,335 person years of follow-up (212 men and 197 women). The Pooled Cohort equations’ set of risk factors demonstrated moderate discrimination ability for ASCVD mortality with modified c-statistics of 0.658 (95% CI: 0.602-0.713), 0.661 (0.589-0.732), and 0.703 (0.624-0.782) for NHW, NHB and MA men respectively. The corresponding c-statistics for women were 0.695 (0.631-0.760), 0.695 (0.624-0.765), and 0.687 (0.588-0.786). Modified Hosmer-Lemeshow χ 2 suggested adequate calibration for NHW men and women (p-value 0.13 and 0.06 respectively). The calibration was borderline adequate for NHB women with p-value 0.04, and inadequate for MA men and women with p-value <0.001 and 0.004 respectively. The moderate discrimination and inadequate calibration for some prediction models might be partly due to the limited sample size. Conclusions: In conclusion, in this nationally representative cohort, the set of risk factors from the Pooled Cohort equations perform adequately to predict 10-year ASCVD mortality for NHW men and women with observed and predicted 10-year ASCVD deaths being similar, and demonstrated moderate discrimination for all sex-race/ethnicity groups.

2021 ◽  
Vol 28 (Supplement_1) ◽  
Author(s):  
M Wong ◽  
J Yap ◽  
KK Yeo

Abstract Funding Acknowledgements Type of funding sources: None. Background and Aims The influence of age and gender on clinical atherosclerotic cardiovascular disease is well reported, but literature remains sparse on whether these extend to the disease in its preclinical stage. We aim to report the prevalence, risk-factors and impact of age and gender on the burden of subclinical coronary atherosclerosis in a healthy Asian population. Methods Healthy subjects aged 30-69 years old, with no history of cardiovascular disease or diabetes were recruited from the general population. Subclinical coronary atherosclerosis was quantified via the Coronary Artery Calcium Score (CACS) with CACS of 0 indicating the absence of calcified plaque, 1 to 10 minimal plaque, 11 to 100 mild plaque, and &gt;100 moderate to severe plaque. Results A total of 663 individuals (mean age 49.4 ± 9.2 years, 44.8% male) were included. The prevalence of any CAC was 29.3% with 9% having CAC &gt; 100.  The prevalence was significantly higher in males than females (43.1 vs 18.0%, p &lt; 0.001). These gender differences became increasingly pronounced with increasing age, especially in those with moderate-severe CAC. Multivariable analysis revealed significant associations between increasing age, male, higher blood pressure, increased glucose levels and higher LDL cholesterol levels with the presence of any CAC. LDL cholesterol was more significantly associated with CAC in females compared to males (Pinteraction = 0.022). Conclusions The prevalence of preclinical atherosclerosis increased with age, and was higher in males than females, with gender-specific differences in associated risk factors. These results will better inform individualised future risk management strategies to prevent the development and progression of coronary artery disease within healthy individuals.


2021 ◽  
Vol 12 ◽  
pp. 215013272098095
Author(s):  
Marwa S. Said ◽  
Inas T. El Sayed ◽  
Eman E. Ibrahim ◽  
Ghada M. Khafagy

Introduction: Cardiovascular disease (CVD) is the most leading cause of mortality worldwide. Changes in diet can reduce subclinical cardiac injury and inflammation in parallel with reductions of other CVD risk factors. Aim: The study aimed to evaluate the beneficial effect of the DASH diet versus usual healthy dietary advice (HDA) on the estimated risk of atherosclerotic cardiovascular disease (ASCVD). Methods: It was a prospective interventional nonrandomized controlled study, conducted on 92 participants attending Family Medicine Outpatient Clinics, Cairo University. The participants were assigned to 2 dietary groups, the DASH and HDA groups, for 12 weeks. All subjects were subjected to anthropometric measurement, assessment of lipid profile, and the estimated cardiovascular risk pre-and post-intervention. Results: The estimated cardiovascular risk was reduced significantly in both the DASH and HDA groups, with no statistically significant difference between the 2 groups regarding the risk reduction. By comparing the percent change between pre and post-intervention in both DASH and HDA groups, the following are the results: BMI dropped by 6.5% versus 2.5%, systolic blood pressure decreased by 6.9% and 4.1%, fasting blood sugar dropped by 5.5% and 3.1%, total cholesterol dropped by 5.2% and 3.1%, LDL dropped by 8.2%, and 3.1%, and HDL increased by 8.2% and 2.4%, in DASH and HDA groups, respectively. Conclusion: Both the DASH diet and HDA are associated with improvement in CVD risk factors. Although better risk factors decline with the DASH diet, there was no statistically significant difference between the 2 groups.


2012 ◽  
Vol 17 (9) ◽  
pp. 1163-1170 ◽  
Author(s):  
Kreton Mavromatis ◽  
Konstantinos Aznaouridis ◽  
Ibhar Al Mheid ◽  
Emir Veledar ◽  
Saurabh Dhawan ◽  
...  

Vascular injury mobilizes bone marrow–derived proangiogenic cells into the circulation, where these cells can facilitate vascular repair and new vessel formation. We sought to determine the relationship between a new biomarker of circulating bone marrow–derived proangiogenic cell activity, the presence of atherosclerotic cardiovascular disease (CVD) and its risk factors, and clinical outcomes. Circulating proangiogenic cell activity was estimated using a reproducible angiogenic colony-forming unit (CFU-A) assay in 532 clinically stable subjects aged 20 to 90 years and ranging in the CVD risk spectrum from those who are healthy without risk factors to those with active CVD. CFU-A counts increased with the burden of CVD risk factors ( p < 0.001). CFU-A counts were higher in subjects with symptomatic CVD than in those without ( p < 0.001). During follow-up of 232 subjects with CVD, CFU-A counts were higher in those with death, myocardial infarction, or stroke than in those without (110 [70–173] vs 84 [51–136], p = 0.01). Therefore, we conclude that circulating proangiogenic cell activity, as estimated by CFU-A counts, increases with CVD risk factor burden and in the presence of established CVD. Furthermore, higher circulating proangiogenic cell activity is associated with worse clinical outcome in those with CVD.


Sign in / Sign up

Export Citation Format

Share Document